| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $65.3M | +25.3% |
| SG&A Expense | $38.6M | -7.5% |
| Operating Income | -$103.9M | -10.7% |
| Interest Expense | $2.3M | +148.2% |
| Pre-tax Income | -$108.7M | -13.5% |
| Net Income | -$108.7M | -13.5% |
| EPS (Basic) | -$1.54 | +36.9% |
| EPS (Diluted) | -$1.54 | +36.9% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $273.7M | +174.6% |
| Current Assets | $281.6M | +171.1% |
| Total Assets | $302.2M | +142.6% |
| Current Liabilities | $38.8M | +20.5% |
| Long-term Debt | $21.9M | +54.7% |
| Total Liabilities | $60.7M | +30.8% |
| Stockholders' Equity | $241.4M | +209.0% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$79.1M | -22.9% |
| Financing Cash Flow | $253.2M | +1058.9% |